Penn Microbiome Therapy - 001 for clostridium infections

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trials ended early. Its trials were stopped early. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 31 May 2019: Trial registered, NCT03970200
  2. 16 Jan 2020: Trial started, NCT03970200
  3. 14 May 2022: Trial terminated, NCT03970200
  4. 30 Oct 2023: Trial results posted, NCT03970200

The trials

NCT03970200: Penn Microbiome Therapy (PMT) for Severe-Clostridium Difficile Infection (CDI)

State
Stopped early
Phase
Phase 2
People
15 taking part
Started
16 Jan 2020
Primary completion
21 Nov 2021
Arms
Lower gastrointestinal Fecal Microbiota Transplantation
Results
Posted on the registry
  1. 31 May 2019: Trial registered
  2. 16 Jan 2020: Trial started
  3. 14 May 2022: Trial terminated
  4. 30 Oct 2023: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Trials ended early

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.